The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FTCH, MGNX and OLLI

In This Article:

NEW YORK, NY / ACCESSWIRE / September 23, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Farfetch Limited (FTCH)
Class Period: all persons and entities who purchased or otherwise acquired Farfetch Class A ordinary shares between September 21, 2018, and August 8, 2019, inclusive, including those who purchased or otherwise acquired Farfetch Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with Company's September 21, 2018 initial public offering.
Lead Plaintiff Deadline: November 18, 2019

During the class period, Farfetch Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company would refuse to reduce merchandise prices to match the rest of the market; (2) this sub-optimal pricing strategy rendered the Company's platform highly susceptible to underpricing by competitors, despite what Defendants touted as a "superior" platform; and (3) as a result, the Company's past and projected Platform Gross Merchandise Value growth rates were foreseeably unsustainable. As a result of the foregoing, Defendants' statements about the Company's business strategy and growth prospects lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in FTCH: http://www.kleinstocklaw.com/pslra-1/farfetch-loss-submission-form?id=3658&from=1

MacroGenics, Inc. (MGNX)
Class Period: February 6, 2019 to June 3, 2019
Lead Plaintiff Deadline: November 12, 2019

The lawsuit alleges MacroGenics, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (a) the Company had conducted the progression-free survival ("PFS") and first interim overall survival ("OS") analyses for the SOPHIA trial by no later than October 10, 2018; (b) the October 2018 PFS analysis showed a 0.9 month improvement in PFS; and (c) the October 2018 OS interim analysis did not produce a statistically significant result and the interim OS Kaplan-Meier curves crossed in several spots (thereby violating the constant hazard assumption) and separated late.

Learn about your recoverable losses in MGNX: http://www.kleinstocklaw.com/pslra-1/macrogenics-inc-loss-submission-form?id=3658&from=1

Ollies Bargain Outlet Holdings, Inc. (OLLI)
Class Period: June 6, 2019 to August 28, 2019
Lead Plaintiff Deadline: November 18, 2019